PHARMINDEX Online

What PHARMINDEX Online does

PHARMINDEX Online, operated by Hungarian private limited company Vidal Next Kft., is a professional pharmaceutical information platform serving exclusively registered Hungarian healthcare professionals — primarily physicians and pharmacists, with secondary use by healthcare institutions. The web-based platform (pharmindex-online.hu), launched in 2017 on a lineage dating to the 1994 print PHARMINDEX, provides a comprehensive drug database covering all medicines marketed in Hungary across all 14 ATC categories, with daily integration of NEAK (National Health Insurance Fund) pricing and subsidy data and source attribution from OGYÉI (national pharmaceutical authority) prescribing information. Core product modules include a multi-modal drug search engine (active ingredient, substitutability, ATC, BNO indication, manufacturer, shortage, and itemized billing search), a drug-drug interaction checker, a suite of clinical calculators (BMI, BRI, ovulation, term date, Framingham stroke risk, energy expenditure), therapeutic guidelines across multiple specialties, and the MediMagister accredited continuing medical education platform. Companion products extend distribution: PHARMINDEX Mobil (Android/iOS mobile app), PHARMINDEX Plus (installable Windows desktop for offline access), and the periodically updated PHARMINDEX Zsebkönyv pocket reference print book. Editorial content is produced by a named in-house team led by Editor-in-Chief Dr. Kaló Anna and Editorial Director Jordán Hajnalka, with scientific journalism staff and an advisory board of practicing cardiologists, gastroenterologists, and internists.

The business model combines three revenue streams: (1) advertising — display and sponsored content with strict editorial controls (no third-party programmatic ad networks), reviewed for evidence-based-medicine alignment and explicitly labeled; (2) professional subscriptions — recurring paid access, primarily annual, to the full drug database, interaction tools, guidelines, calculators, and editorial content behind authenticated PHARMINDEX accounts; and (3) professional services — participant fees for MediMagister accredited CME/CPD, plus modest certification-reporting fees (HUF 1,500 + VAT) for pharmaceutical manufacturers, government, and academic registrants. Distribution is sales-led with self-serve digital access for registered professionals; marketing relies on content marketing across 28 clinical specialty columns, SEO positioning as a Google 'Preferred Source' for medical queries, organic Facebook sharing, email notifications, and engagement through the MediMagister CME channel. The company is privately held with no disclosed funding, no parent company, and operates exclusively in Hungary with no evidence of international expansion or external investment.

Name

PHARMINDEX Online

Legal name

Vidal Next Kft.

Website

https://pharmindex-online.hu

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

PHARMINDEX Online is a Hungarian B2B pharmaceutical information platform serving registered physicians and pharmacists with a daily-updated drug database, NEAK pricing integration, clinical calculators, drug-interaction tools, and accredited CME via MediMagister.

Ownership category

akta.pro rank

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Advertising Revenue: PHARMINDEX Online generates revenue from advertising. The website displays advertisements and sponsored content. The publisher exercises editorial control over advertising, requires 'Hirdetés' (Advertisement) labels, and reviews all ads for legal compliance and alignment with evidence-based medicine standards. The website does not allow uncontrolled third-party advertising (e.g., Google Ads). PR articles are clearly labeled as such.
2. Professional Subscriptions: PHARMINDEX Online is primarily accessible to registered healthcare professionals. The site states that most content is only viewable after login. Subscription/membership is required for full access to drug databases, detailed prescribing information, and professional tools. The site directs prospective subscribers to www.pharmindex.hu for product ordering and subscription details.
3. MediMagister Continuing Education Fees: The MediMagister continuing education platform operates partly on participant fees (részvételi díjak) in addition to advertising/sponsorship revenue. Certain user types (pharmaceutical manufacturers, government, higher education/research registrations) pay a reporting fee of HUF 1,500 + VAT for certification reporting.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

PHARMINDEX Online is a subscription-based pharmaceutical information portal for Hungarian healthcare professionals, providing a comprehensive drug database of all medicines marketed in Hungary, integrated with NEAK pricing and subsidy data, drug interaction checking, therapeutic guidelines, clinical calculators, and accredited continuing medical education via the MediMagister module. The platform is distributed through the web, mobile apps (Android/iOS), a desktop application, and a print pocket reference book.

Product overview

PHARMINDEX Online is a comprehensive web-based pharmaceutical information platform for healthcare professionals in Hungary, comprising the core PHARMINDEX Online database alongside complementary products including PHARMINDEX Mobil (mobile app for Android/iOS), PHARMINDEX Plus (installable desktop application), PHARMINDEX Zsebkönyv (pocket reference book), and PHARMINDEX MediMagister (accredited continuing education platform). The ecosystem includes specialized tools such as therapeutic guidelines, health calculators (BRI, BMI, ovulation, term, stroke, energy), and reference databases for medical terminology, E-numbers, and laboratory tests. The platform organizes content across 25 medical specialty rovat (sections) including cardiology, oncology, neurology, and others, providing news articles and clinical research summaries alongside structured pharmaceutical databases.

Differentiator

Problem solved

Functional benefit

Brands

• PHARMINDEX Mobil: Mobile application based on PHARMINDEX data providing drug information knowledge base for Android and iOS.
• PHARMINDEX Plus
• PHARMINDEX Zsebkönyv
• MediMagister

Products and services

• PHARMINDEX Online A comprehensive web-based pharmaceutical information database and portal for healthcare professionals, providing drug search tools (active ingredient, substitutability, ATC, BNO indication, manufacturer, shortage search), drug interaction checking, itemized billing search, drug database changes, and subscription-gated access to detailed prescribing and pricing information.
• PHARMINDEX Mobil A mobile application for Android and iOS based on PHARMINDEX data, providing a drug information knowledge base for healthcare professionals on the go.
• PHARMINDEX Plus An installable, updatable, portable drug information knowledge base for Windows, offering offline access to pharmaceutical data for healthcare professionals who need a standalone desktop tool.
• PHARMINDEX Zsebkönyv A pocket reference book publication containing pharmaceutical information, updated periodically with new editions for healthcare professionals.
• PHARMINDEX MediMagister A continuing education platform within PHARMINDEX Online offering accredited professional training courses for healthcare professionals, with credit point reporting.

Quantifiable outcome

• PHARMINDEX Online is Hungary's first comprehensive drug information website (launched 2017), building on the PHARMINDEX brand established in 1994
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• NEAK (Nemzeti Egészségbiztosítási Alapkezelő / National Institute of Health Insurance Fund Management)coreTechnology or IntegrationPHARMINDEX Online integrates NEAK drug pricing and subsidy data into its database. The platform displays the validity date of pricing data sourced from NEAK (as of source data: 2026-07-01). NEAK is the Hungarian government body responsible for health insurance fund management and drug reimbursement pricing.
• Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet (OGYÉI)coreTechnology or IntegrationPHARMINDEX Online uses official OGYÉI-approved prescribing information (alkalmazási előírásokat és betegtájékoztatókat) as the authoritative source for drug information. The platform directs users to consult OGYÉI official prescribing information as the primary authority.
• Magyar Posta Zrt.minorOthersMagyar Posta Zrt. (Hungarian Post Ltd.) is listed as a data processor for delivering prizes won by users in PHARMINDEX promotions/lotteries. Address: 3512 Miskolc, Hungary.
• Fürgefutár.hu Kft.minorOthersFürgefutár.hu Kft. is listed as a data processor for logistics/delivery of prizes from PHARMINDEX promotions. Address: 1122 Budapest, Maros utca 12.
• Webshippy Magyarország Logisztikai és Szállítási Kft.minorOthersWebshippy Magyarország Logisztikai és Szállítási Kft. is listed as a data processor for logistics/delivery of prizes from PHARMINDEX promotions. Address: 1044 Budapest, Ezred utca 2. B. ép. 13.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Drugs.com: Widely used drug information database offering professional drug references, interaction checking, and consumer-facing content. Comparable in core drug information functionality but more consumer-skewed than PHARMINDEX's HCP-only model.

Regional players

• Házipatika.com: Leading Hungarian consumer health information portal. Comparable Hungarian-language health information destination but consumer-targeted rather than HCP-only, and lacks PHARMINDEX's regulatory-grade NEAK/OGYÉI integrations.

Broad incumbents

• Elsevier ClinicalKey: Elsevier's clinical search engine and reference platform combining drug information, clinical guidelines, journals, and CME. Comparable in offering breadth across clinical reference, drug data, and education for HCPs — but at global enterprise scale.
• DynaMed (EBSCO): Clinical reference tool providing evidence-based drug and disease information for clinicians; comparable to PHARMINDEX's clinical decision support and therapeutic guidelines modules, but globally distributed and larger scale.
• Merative (Micromedex): Hospital-grade drug reference and clinical decision support platform used widely in US and global health systems. Comparable professional drug reference functionality to PHARMINDEX but distributed at enterprise/health-system level internationally.
• Medscape: WebMD-owned professional medical news, reference, and CME platform serving physicians globally. Comparable to PHARMINDEX's combination of clinical news, drug information, and accredited continuing education (MediMagister) under one destination for HCPs.
• Wolters Kluwer (Lexicomp / UpToDate / Medi-Span): Global medical information incumbent whose Lexicomp and Medi-Span products are direct equivalents to PHARMINDEX's drug database; UpToDate overlaps on therapeutic guidelines and clinical decision support. Comparable in product scope but vastly larger and multi-country.

Direct peers

• Rote Liste (Germany): Germany's authoritative pharmaceutical reference compendium for healthcare professionals, with similar professional drug information, manufacturer data, and pricing references. Comparable content model in a different geography.
• Vidal (France): France's leading professional pharmaceutical reference; the PHARMINDEX operating entity (Vidal Next Kft.) is named after this lineage. Same core offering: structured drug database, interaction checker, and subscription access for HCPs — but serving the French market.
• Compendium of Pharmaceuticals and Specialties (CPS): Canadian Pharmacists Association's authoritative drug information compendium for Canadian HCPs. Closest analog in offering model — a professionally curated national drug reference with subscription access — but serves the Canadian market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/PHARMINDEX
• LinkedInlinkedin.com/company/vidal-next

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PHARMINDEX Online